Point72 Asset Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-591,747
| Closed | -$48.9M | – | 2234 |
|
|
2024
Q4 | $48.9M | Buy |
591,747
+446,166
| +306% | +$35.2M | 0.11% | 221 |
|
|
2024
Q3 | $10.4M | Buy |
+145,581
| New | +$10.3M | 0.03% | 633 |
|
|
2023
Q3 | – | Sell |
-937,300
| Closed | -$55.8M | – | 2619 |
|
|
2023
Q2 | $55.8M | Buy |
937,300
+933,800
| +26,680% | +$53.2M | 0.17% | 158 |
|
|
2023
Q1 | $198K | Buy |
+3,500
| New | +$224K | ﹤0.01% | 1487 |
|
|
2022
Q2 | – | Sell |
-82,650
| Closed | -$6.1M | – | 1478 |
|
|
2022
Q1 | $6.1M | Sell |
82,650
-177,800
| -68% | -$12.4M | 0.02% | 649 |
|
|
2021
Q4 | $18.8M | Buy |
260,450
+192,550
| +284% | +$14M | 0.08% | 352 |
|
|
2021
Q3 | $5.2M | Sell |
67,900
-87,900
| -56% | -$7.06M | 0.02% | 654 |
|
|
2021
Q2 | $12.1M | Buy |
155,800
+124,500
| +398% | +$8.85M | 0.05% | 404 |
|
|
2021
Q1 | $1.93M | Sell |
31,300
-217,300
| -87% | -$13.8M | 0.01% | 733 |
|
|
2020
Q4 | $16.2M | Buy |
248,600
+196,783
| +380% | +$11.3M | 0.08% | 327 |
|
|
2020
Q3 | $2.57M | Buy |
51,817
+14,095
| +37% | +$727K | 0.01% | 670 |
|
|
2020
Q2 | $1.8M | Buy |
+37,722
| New | +$1.82M | 0.01% | 611 |
|
|
2020
Q1 | – | Sell |
-155,278
| Closed | -$9.14M | – | 892 |
|
|
2019
Q4 | $9.14M | Buy |
155,278
+88,578
| +133% | +$4.81M | 0.05% | 393 |
|
|
2019
Q3 | $3.41M | Buy |
+66,700
| New | +$3.18M | 0.02% | 522 |
|
|
2019
Q2 | – | Sell |
-485,330
| Closed | -$24M | – | 1402 |
|
|
2019
Q1 | $24M | Buy |
+485,330
| New | +$22M | 0.11% | 213 |
|
|
2018
Q4 | – | Sell |
-150,577
| Closed | -$8.55M | – | 1061 |
|
|
2018
Q3 | $8.55M | Buy |
150,577
+72,013
| +92% | +$3.79M | 0.04% | 492 |
|
|
2018
Q2 | $3.96M | Sell |
78,564
-478,434
| -86% | -$24.9M | 0.02% | 659 |
|
|
2018
Q1 | $27.8M | Buy |
556,998
+104,195
| +23% | +$4.9M | 0.12% | 225 |
|
|
2017
Q4 | $18.6M | Buy |
452,803
+9,103
| +2% | +$319K | 0.08% | 310 |
|
|
2017
Q3 | $13.2M | Buy |
+443,700
| New | +$13.5M | 0.06% | 343 |
|
|
2017
Q2 | – | Sell |
-388,700
| Closed | -$11.5M | – | 891 |
|
|
2017
Q1 | $11.5M | Sell |
388,700
-25,680
| -6% | -$701K | 0.06% | 369 |
|
|
2016
Q4 | $10.3M | Buy |
+414,380
| New | +$9.42M | 0.07% | 307 |
|
|
2015
Q3 | – | Sell |
-659,525
| Closed | -$16.9M | – | 823 |
|
|
2015
Q2 | $16.9M | Buy |
659,525
+135,925
| +26% | +$3.44M | 0.12% | 224 |
|
|
2015
Q1 | $13.2M | Sell |
523,600
-266,200
| -34% | -$6.49M | 0.09% | 271 |
|
|
2014
Q4 | $18.8M | Buy |
+789,800
| New | +$17.5M | 0.13% | 220 |
|
|
2014
Q3 | – | Sell |
-351,000
| Closed | -$8.4M | – | 695 |
|
|
2014
Q2 | $8.4M | Buy |
+351,000
| New | +$8.47M | 0.05% | 362 |
|
Other funds holding GMED
BAM
SC
Point72 Asset Management's GMED Position: Q1 2025 in Review
Point72 Asset Management sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 591,747 shares — an estimated $48.9M sold.
Point72 Asset Management first reported a position in GMED in Q2 2014 and held it in 26 quarters. The position peaked at $55.8M in Q2 2023. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.
- Point72 Asset Management reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
- Point72 Asset Management sold 591,747 Globus Medical shares in Q1 2025, an estimated $48.9M.
- Point72 Asset Management first reported a position in Globus Medical in Q2 2014 and held it in 26 quarters.
- Point72 Asset Management's Globus Medical position peaked at $55.8M in Q2 2023.
- 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.
Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.